Hexokinase

Other Metabolism Related Inhibitors

Dehydrogenase Transferase DPP Aminopeptidase Procollagen C Proteinase P450 (e.g. CYP17) Phospholipase (e.g. PLA) Factor Xa PDE DHFR

Cat.No.	Product Name	Information	Product Use Citations	Product Validations
S4701	2-DG (2-Deoxy-D-glucose)	2-DG (2-Deoxy-D-glucose), an analog of glucose, is a glycolytic inhibitor with antiviral activity. 2-Deoxy-D-glucose induces apoptosis and inhibits Herpes Simplex Virus type-1 (HSV-1) receptor expression.	Signal Transduct Target Ther, 2025, 10(1):341 Nat Commun, 2025, 16(1):212 Cancer Commun (Lond), 2025, 10.1002/cac2.70036
S2610	Lonidamine	Lonidamine is an orally administered small molecule hexokinase inactivator.	Signal Transduct Target Ther, 2025, 10(1):341 Cancer Lett, 2024, 589:216824 iScience, 2024, 27(10):110862

Cat.No.

Product Name

Information

Product Use Citations

Product Validations

S4701

2-DG (2-Deoxy-D-glucose)

2-DG (2-Deoxy-D-glucose), an analog of glucose, is a glycolytic inhibitor with antiviral activity. 2-Deoxy-D-glucose induces apoptosis and inhibits Herpes Simplex Virus type-1 (HSV-1) receptor expression.

Signal Transduct Target Ther, 2025, 10(1):341

Nat Commun, 2025, 16(1):212

Cancer Commun (Lond), 2025, 10.1002/cac2.70036

Verified customer review of 2-DG (2-Deoxy-D-glucose)

S2610

Lonidamine

Lonidamine is an orally administered small molecule hexokinase inactivator.

Signal Transduct Target Ther, 2025, 10(1):341

Cancer Lett, 2024, 589:216824

iScience, 2024, 27(10):110862